Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics.
作者信息
Finsterer Josef
机构信息
Neurology Department Neurology & Neurophysiology Center Vienna Austria.
出版信息
Health Sci Rep. 2024 Nov 7;7(11):e70197. doi: 10.1002/hsr2.70197. eCollection 2024 Nov.
Abstract
摘要
相似文献
1
Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics.帕金森病、帕金森叠加综合征、路易体病和阿尔茨海默病性痴呆的检查应包括单光子发射计算机断层扫描（SPECT）、正电子发射断层扫描（PET）和遗传学检查。
Health Sci Rep. 2024 Nov 7;7(11):e70197. doi: 10.1002/hsr2.70197. eCollection 2024 Nov.
2
Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.路易体痴呆的运动和认知功能：与阿尔茨海默病和帕金森病的比较。
J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):243-52. doi: 10.1136/jnnp.62.3.243.
3
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?路易体痴呆和帕金森病痴呆是同一种疾病吗？
BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.
4
Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.鉴别路易体痴呆与阿尔茨海默病及帕金森病痴呆：影像学方法的最新进展。
J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29.
5
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.帕金森病、路易体痴呆和阿尔茨海默病中尼古丁结合位点的改变：早期神经病理学的可能指标。
Neuroscience. 1995 Jan;64(2):385-95. doi: 10.1016/0306-4522(94)00410-7.
6
Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia.帕金森病与帕金森叠加综合征、路易体痴呆和阿尔茨海默病痴呆的关联。
Health Sci Rep. 2024 Mar 31;7(4):e2019. doi: 10.1002/hsr2.2019. eCollection 2024 Apr.
7
Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease.阿尔茨海默病合并脑路易体病中的心脏交感神经去神经支配和α-突触核蛋白病
Brain Commun. 2020;2(1):fcaa004. doi: 10.1093/braincomms/fcaa004. Epub 2020 Jan 28.
8
Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.在突触核病和阿尔茨海默病中鉴定 tau 过度磷酸化和 tau 激酶激活的部位。
PLoS One. 2013 Sep 20;8(9):e75025. doi: 10.1371/journal.pone.0075025. eCollection 2013.
9
Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.溶酶体多基因风险与路易体病神经病理学严重程度相关。
Brain. 2023 Oct 3;146(10):4077-4087. doi: 10.1093/brain/awad183.
10
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.帕金森病认知障碍的多因素性：一项神经心理学研究。
Acta Neurol Scand. 2020 Jun;141(6):500-508. doi: 10.1111/ane.13226. Epub 2020 Feb 27.
本文引用的文献
1
Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia.帕金森病与帕金森叠加综合征、路易体痴呆和阿尔茨海默病痴呆的关联。
Health Sci Rep. 2024 Mar 31;7(4):e2019. doi: 10.1002/hsr2.2019. eCollection 2024 Apr.
2
Parkinson's disease - genetic cause.帕金森病——遗传病因。
Curr Opin Neurol. 2023 Aug 1;36(4):292-301. doi: 10.1097/WCO.0000000000001167. Epub 2023 May 24.
3
Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?在分子成像时代，脑单光子发射计算机断层扫描作为痴呆症神经退行性变的生物标志物：仍是一个有效的选择吗？
Front Neurol. 2021 May 10;12:629442. doi: 10.3389/fneur.2021.629442. eCollection 2021.
4
Novel mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy.一位早发性帕金森病、进行性眼外肌麻痹和视神经萎缩患者的新型突变。
Int J Neurosci. 2020 Apr;130(4):319-321. doi: 10.1080/00207454.2019.1681422. Epub 2019 Nov 7.
5
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理：DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
6
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.123I-碘氟潘 SPECT 多巴胺转运体成像的 SNM 实践指南 1.0
J Nucl Med. 2012 Jan;53(1):154-63. doi: 10.2967/jnumed.111.100784. Epub 2011 Dec 8.
Zotero 插件